Abstracts

HTA recommendations for biosimilars implementation in oncology field in MENA region

Background With the presence of concept of biosimilar products at last decade which defined by WHO as a biotherapeutic product which is similar in terms of quality, safe...

A. Abotaleb ;

06/27/2022

Time intervals from presentation to treatment of colorectal cancer in Libya: A study of cases referred to medical oncology at Tripoli University Hospital, Tripoli, Libya in 2021

Background Colorectal cancer is the second most common cancer in Libya with increasing trends faster than other countries and a high mortality rate. Reports indicate tha...

06/27/2022

Outcomes using induction chemotherapy followed by long-course chemoradiotherapy as total neoadjuvant therapy for locally advanced rectal cancer

Background Total neoadjuvant therapy (TNT) for rectal cancer is being adopted worldwide as a promising means to improve outcomes for patients with locally advanced recta...

06/27/2022

Overexpression of survivin-1, TAG-72 and HERC5 in patients diagnosed with hepatocellular carcinoma in the Black Sea Coast geographical area

Background Epidemiological data regarding hepatocellular carcinoma (HCC) report unsatisfactory morbimortality rates despite the global efforts to decrease the incidence ...

06/27/2022

Gastrointestinal stromal tumours: Real-world data from a Portuguese oncological center

Background Gastrointestinal Stromal Tumours (GIST) are rare tumours that account for less than 3% of all gastrointestinal tumours. Originating from the myenteric interst...

06/27/2022

Comparison of clinicopathological and survival features of right and left colon cancers: Experience of the medical oncology department of Fez

Background Right-sided colon cancers (RCC) and left-sided colon cancers (LCC) have different epidemiological, physiological, pathological, genetic, and clinical characte...

Lamiae Amaadour ;

Karima Oualla ;

Samia Arifi ;

Soukaina El Anssari ;

Zineb Benbrahim ;

Youssef Elhaitmy ;

Imad Elbadisy ;

Fouad Abbass ;

06/27/2022

The efficacy of preoperative imatinib in locally advanced gastrointestinal stromal tumors: A single-center retrospective analysis

Background Preoperative imatinib has been confirmed as a proper down-staging method for gastrointestinal stromal tumors (GISTs). The study aimed to explore the efficacy ...

06/27/2022

Germline testing in pancreatic adenocarcinoma

Background Pancreatic ductal adenocarcinoma (PDAC) remains a challenging disease to treat. Despite advances in medical therapies, the 5-year survival rate remains below ...

Martín M. Navarro ;

Gómez T. Martín ;

Sarmiento R. González ;

Tamayo R. Seijas ;

Brage E. Terán ;

Tocino R. Vidal ;

Gutiérrez A. López ;

Sánchez E. Fonseca ;

Hernández J. Cruz ;

Tapia E. Sánchez ;

García J. Pérez ;

06/27/2022

Prognostic value of CD3+CD8+ T lymphocytes in advanced and metastatic PDAC

Background T cells traffic into the tumor microenvironment, and exhibit cytotoxicity against tumor cells. Infiltration by cytotoxic CD3+CD8+ lymphocytes is associated wi...

06/27/2022

Claudin-16, its clinical and prognostic value in colorectal cancer

Background Claudin-16, also known as CLDN-16 or paracellin-1, plays a major role in tight junction-specific occlusion of the intercellular space, through calcium-indepen...

06/27/2022